Claudia Manriquez Roman

Author

Mayo Clinic ORCID

Also Known As

C. Manriquez Roman, Claudia Manriquez Roman

Publications

423

Citations

H-Index

Concepts

All Affiliations

Mayo Clinic Mayo Clinic in Arizona Mayo Clinic in Florida University of Minnesota MorphoSys (Germany)

About

Claudia Manriquez Roman is an author at Mayo Clinic specializing in tumor microenvironment, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	54
2	Immunology	2	2	54
3	Cell Biology	1	1	36
4	Cellular Therapies	1	1	18
5	Pathology	1	1	18

Claudia Manriquez Roman

Publications

365

Citations

H-Index

Page 1

	Year	Citations
Targeting cancer-associated fibroblasts in the bone marrow prevents resistance to CART-cell therapy in multiple myeloma Reona Sakemura, Mehrdad Hefazi, Elizabeth L. Siegler, Blood	2022	130
Leukemic extracellular vesicles induce chimeric antigen receptor T cell dysfunction in chronic lymphocytic leukemia Michelle J. Cox, Fabrice Lucien, Reona Sakemura, Molecular Therapy	2020	72
GM-CSF disruption in CART cells modulates T cell activation and enhances CART cell anti-tumor activity Michelle J. Cox, Claudia Manriquez Roman, Erin E. Tapper, Leukemia Cancer ImmunosurveillanceGm-csf DisruptionT-regulatory CellImmunologyImmunoediting	2022	36
Development of a Clinically Relevant Reporter for Chimeric Antigen Receptor T-cell Expansion, Trafficking, and Toxicity Reona Sakemura, Aditya Bansal, Elizabeth L. Siegler, Cancer Immunology Research	2021	27
IL-4 drives exhaustion of CD8+ CART cells Carli M. Stewart, Elizabeth L. Siegler, Reona Sakemura, Nature Communications	2024	27
Targeting Cancer Associated Fibroblasts in the Bone Marrow Prevents Resistance to Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma Reona Sakemura, Michelle J. Cox, Michael J. Hansen, Blood	2019	19
CD19 occupancy with tafasitamab increases therapeutic index of CART19 cell therapy and diminishes severity of CRS Reona Sakemura, Claudia Manriquez Roman, Paulina Horvei, Blood Cell TherapyT-regulatory CellImmunologyPathologyImmunotherapy	2023	18
Efficient Gene Editing of CART Cells with CRISPR-Cas12a for Enhanced Antitumor Efficacy Elizabeth L. Siegler, Brandon W. Simone, Reona Sakemura, Blood	2020	14
Targeting of CD19 By Tafasitamab Does Not Impair CD19 Directed Chimeric Antigen Receptor T Cell Activity in Vitro Paulina Horvei, Reona Sakemura, Michelle J. Cox, Blood	2019	12
AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T Cells Reona Sakemura, Mehrdad Hefazi, Michelle J. Cox, Cancer Immunology Research	2023	10

Page 1